Mortality News and Research

RSS

Study shows a rise in blood pressure during COVID-19

In a recent study published in the journal Hypertension, researchers examined blood pressure (BP) outcomes in individuals with hypertension during the coronavirus disease 2019 (COVID-19) pandemic.

3 Nov 2022

Novel monoclonal antibodies NA8 and NE12 can neutralize most SARS-CoV-2 variants and Omicron subvariants

Researchers generated and characterized two monoclonal antibodies (NA8 and NE12) that target the receptor binding domain of the SARS-CoV-2 spike protein, and exhibit neutralizing activity against major SARS-CoV-2 variants of concern.

3 Nov 2022

Ventilation rates need to increase substantially to bring down Omicron infection probability

With SARS-CoV-2 variants continuing to evolve, building scientists and air quality specialists have assessed the ventilation rates of rooms required to keep the risk of infection under one percent, concluding that Omicron and its sublineages require ventilation some 50 times greater than the virus did when humanity first encountered it in the spring of 2020.

3 Nov 2022

Experts estimate the prevalence of breast cancer survivors in Canada

It was the information she couldn't find that led Amy Kirkham, an assistant professor in the University of Toronto's Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.

3 Nov 2022

Political divide and public opinion influence racial disparities in COVID-19 mortality

Researchers at the University of Wisconsin-Madison and the University of California-Los Angeles investigated how political polarization in the United States (US) shaped the time-varying patterns of racial inequality in coronavirus disease 2019 (COVID-19) mortality since the onset of the pandemic.

3 Nov 2022

Study identifies a new therapeutic strategy to tackle endometrial cancer

Inhibition of the ERK5 protein kinase reduces the proliferation and survival of endometrial cancer cells, and potentiates standard chemotherapy.

2 Nov 2022

An optimal approach to treat femoropopliteal lesions

New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.

2 Nov 2022

Progress and challenges in the development of mRNA vaccines against respiratory syncytial virus

New research discussed the structure and life cycle of respiratory syncytial virus (RSV), the current research on the treatment and prevention of RSV infections, and the advancements in RSV mRNA vaccine technology after the surge in vaccine research during the COVID-19 pandemic.

1 Nov 2022

What is the dose-response association of device-measured vigorous physical activity with mortality and incident cardiovascular disease and cancer?

Researchers demonstrated the benefits of moderate amounts of vigorous physical activity (VPA) completed in short bouts in reducing the risk of heart diseases and cancers.

1 Nov 2022

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

Researchers demonstrated how interferon-stimulated gene 15 (ISG15) is involved in the Vaccinia virus (VACV) dissemination.

1 Nov 2022

What makes some humans mosquito magnets?

Researchers explored the reasons for the greater attractiveness of some individuals to mosquitoes.

1 Nov 2022

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Institute of Human Virology researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million.

31 Oct 2022

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Researchers estimate the severity of infection with the SARS-CoV-2 Omicron BA.2 subvariant as compared to that caused by the Delta and Omicron variants.

31 Oct 2022

Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

Researchers from Italy investigated the risk of SARS-CoV-2 reinfection and hospitalization among individuals with vaccinations and previous SARS-CoV-2 infections.

31 Oct 2022

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

A new study aimed to analyze the association between lifestyle risk factors, PRSs, and their interactions along with the risk of CVE within 90 days post-COVID-19 diagnosis.

31 Oct 2022

New report on the impact of monkeypox on people with HIV

Researchers describe the presentation of patients severely infected with the monkeypox virus.

30 Oct 2022

'What pediatricians need to know' about monkeypox in children

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

28 Oct 2022

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the Phase 1 clinical study, recently labeled as a "national priority" by CAPNET (National Steering Committee for Therapeutic Trials and other Research on Covid-19).

28 Oct 2022

Specific stem cell protein found to be involved in the recurrence of medulloblastoma

The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers at Uppsala University have discovered a certain protein that makes tumor cells resting and insensitive to radiation treatment.

28 Oct 2022

What are the contemporary hazards of cigarette smoking and benefits of quitting smoking by race, ethnicity, and sex among US adults?

Researchers quantified the association between cigarette smoking and all-cause and cause-specific deaths by sex, ethnicity, and race.

28 Oct 2022

Mortality News and Research

Study shows a rise in blood pressure during COVID-19

Novel monoclonal antibodies NA8 and NE12 can neutralize most SARS-CoV-2 variants and Omicron subvariants

Ventilation rates need to increase substantially to bring down Omicron infection probability

Experts estimate the prevalence of breast cancer survivors in Canada

Political divide and public opinion influence racial disparities in COVID-19 mortality

Study identifies a new therapeutic strategy to tackle endometrial cancer

An optimal approach to treat femoropopliteal lesions

Progress and challenges in the development of mRNA vaccines against respiratory syncytial virus

What is the dose-response association of device-measured vigorous physical activity with mortality and incident cardiovascular disease and cancer?

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

What makes some humans mosquito magnets?

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

New report on the impact of monkeypox on people with HIV

'What pediatricians need to know' about monkeypox in children

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

Specific stem cell protein found to be involved in the recurrence of medulloblastoma

What are the contemporary hazards of cigarette smoking and benefits of quitting smoking by race, ethnicity, and sex among US adults?

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News